Clinical Trials Logo

Filter by:
NCT ID: NCT01228682 Active, not recruiting - SIADH Clinical Trials

Post-Authorisation Safety Study of Samsca (Tolvaptan) Used in Routine Medical Practice

Start date: October 2010
Phase: N/A
Study type: Observational

A Drug Utilisation Survey is performed to monitor and document the drug utilisation patterns of Samsca in routine medical practice. A Post-Authorisation Safety Study is performed to collect information on the safety of Samsca when used in a real-life setting.

NCT ID: NCT01228201 Completed - Clinical trials for Coronary Artery Disease

Physical Exercise and Coronary Artery Plaque Composition

Start date: November 2010
Phase: N/A
Study type: Interventional

The purpose of this study is to examine the effect of two different physical exercise protocols on changes in coronary artery plaque composition and development of in-stent restenosis in patients treated with percutaneous coronary intervention with stent implantation. The investigators will compare aerobic interval training and moderate continuous training. Both exercise protocols have a duration of 12 weeks. The investigators hypothesize that aerobic interval training is superior to moderate continuous training regarding effects on the composition of coronary artery plaques and a reduction in the development of in-stent restenosis.

NCT ID: NCT01226017 Completed - Clinical trials for Animal Assisted Therapy

A Possible Effect of Oxytocin During Interaction Between Humans and Animals

Oxytocin2010
Start date: October 2010
Phase: N/A
Study type: Interventional

The purpose of this pilot study is to investigate the possible change of Oxytocin level in human blood after positive interaction with farm animals.

NCT ID: NCT01225822 Completed - Clinical trials for Venous Thromboembolism

BIBR 1048 Dose Range Finding Study in Prevention of Venous Thromboembolism in Patients With Primary Elective Total Hip or Knee Replacement Surgery

Start date: November 2002
Phase: Phase 2
Study type: Interventional

The primary objective of this study is to establish the dose-response relationship with regard to efficacy and safety of BIBR 1048 (50 mg bis in die(b.i.d), 150 mg b.i.d, 225 mg b.i.d. and 300 mg quaque die(q.d) ) in preventing venous thromboembolism(VTE) in patients undergoing primary elective total hip and knee replacement.

NCT ID: NCT01225562 Completed - Stroke Clinical Trials

Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin

PEGASUS
Start date: October 2010
Phase: Phase 3
Study type: Interventional

This study is being carried out to see if a new drug called ticagrelor given twice daily in addition to the ASA therapy decreases the frequency of cardiovascular events (e.g., death from heart disease, heart attack, or stroke).

NCT ID: NCT01224925 Completed - Reversible Pulpitis Clinical Trials

RCT of Pulp Capping Over Carious Exposure in Adults

Start date: October 18, 2010
Phase: N/A
Study type: Interventional

This multicentre study was a randomized, controlled, parallel, patient-blinded, two-arm superiority trial with a 1:1 allocation ratio that followed the CONSORT guidelines.The aim of this study was to investigate whether MTA is more effective than a conventional calcium hydroxide liner (Dycal®) as a direct pulp capping material in mature molar teeth with a carious pulpal exposure.

NCT ID: NCT01223209 Completed - Carcinoma Clinical Trials

A Study, Combination, Immunologic Study of LTX-315 as Adjunct to GV1001 in Patients Following Curative Surgery for Carcinoma

Start date: August 2010
Phase: Phase 1
Study type: Interventional

This study involves testing of the medicine LTX-315 combined with a cancer vaccine (GV1001). This will be tested in patients that have had surgery with curative intent for malignant tumour. GV1001 is a peptide vaccine in development to treat cancer. An adjuvant, is required to start the immune response in the body to have effect of GV-1001. LTX-315, also a peptide, in development for cancer treatment. In this study, the investigators wish to find out whether LTX-315 can make GV1001 more effective at stimulating the immune system.

NCT ID: NCT01223170 Completed - Clinical trials for Cardiovascular Diseases

eRehab: Can Information and Communication Technology (ICT) Enhance Self-management of Cardiovascular Disease?

eRehab
Start date: January 2012
Phase: N/A
Study type: Interventional

Cardiovascular Diseases (CVD) according to the World Health Organization (WHO) are leading causes of death and represent 30% of all global deaths and 48% of the deaths in Europe. Moreover, the current trends predict increase in deaths caused by Cardiovascular Diseases over the next years. Secondary preventive efforts can decrease mortality risk as well as improve health among Cardiovascular Disease patients. This study suggests an innovative approach in supporting the self-management of Cardiovascular Disease patients after rehabilitation. The implied Randomized Controlled Trial has two arms and aims to investigate the effectiveness of tailoring in an Information and Communication Technology (ICT) based intervention. The tailoring will be based on concepts derived from health psychology theories, and will contribute in their further development. More specifically: - Aim 1: To assess the needs of CVD rehabilitation patients that can potentially be met through the use of ICT. - Aim 2: To assess the effects of a tailored Internet-based intervention on maintenance of self-management behaviors after a rehabilitation stay. Hypothesis: The intervention group (tailored) will have higher adherence a) to the Internet-based intervention, and b) to self-management. - Aim 3: To assess the effect of mobile technology with activity sensors on physical activity. Hypothesis: There will be a relationship between the data collected from activity sensors and the self-reported physical activity levels.

NCT ID: NCT01223027 Completed - Clinical trials for Metastatic Renal Cell Carcinoma

Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma

Start date: March 2011
Phase: Phase 3
Study type: Interventional

This study will evaluate the safety and efficacy of Dovitinib versus sorafenib in patients with metastatic renal cell cancer.

NCT ID: NCT01221116 Terminated - Heart Failure Clinical Trials

Inotropic Treatment With Levosimendan (SimdaxR)in Heart Surgery

Start date: January 2003
Phase: N/A
Study type: Interventional

Hypothesis: Treatment with levosimendan will preserve myocardial function and hemodynamics after cardiac surgery and lead to reduced stay at intensive care unit